Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
- 26 May 2015
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 112 (23), 7153-7158
- https://doi.org/10.1073/pnas.1507719112
Abstract
Serum biomarkers in Duchenne muscular dystrophy (DMD) may provide deeper insights into disease pathogenesis, suggest new therapeutic approaches, serve as acute read-outs of drug effects, and be useful as surrogate outcome measures to predict later clinical benefit. In this study a large-scale biomarker discovery was performed on serum samples from patients with DMD and age-matched healthy volunteers using a modified aptamer-based proteomics technology. Levels of 1,125 proteins were quantified in serum samples from two independent DMD cohorts: cohort 1 (The Parent Project Muscular Dystrophy–Cincinnati Children’s Hospital Medical Center), 42 patients with DMD and 28 age-matched normal volunteers; and cohort 2 (The Cooperative International Neuromuscular Research Group, Duchenne Natural History Study), 51 patients with DMD and 17 age-matched normal volunteers. Forty-four proteins showed significant differences that were consistent in both cohorts when comparing DMD patients and healthy volunteers at a 1% false-discovery rate, a large number of significant protein changes for such a small study. These biomarkers can be classified by known cellular processes and by age-dependent changes in protein concentration. Our findings demonstrate both the utility of this unbiased biomarker discovery approach and suggest potential new diagnostic and therapeutic avenues for ameliorating the burden of DMD and, we hope, other rare and devastating diseases.Keywords
Funding Information
- U.S. Department of Education (H133B031118)
- U.S. Department of Education (H133B090001)
- U.S. Department of Defense (W81XWH-09-1-0592)
- HHS | National Institutes of Health (UL1RR031988)
- HHS | National Institutes of Health (U54HD053177)
- HHS | National Institutes of Health (UL1RR024992)
- HHS | National Institutes of Health (U54RR026139)
- HHS | National Institutes of Health (2U54HD053177)
- HHS | National Institutes of Health (G12RR003051)
- HHS | National Institutes of Health (R01AR062380)
- HHS | National Institutes of Health (P50AR060836)
- HHS | National Institutes of Health (R24HD050846)
- HHS | National Institutes of Health (P30HD040677)
- HHS | National Institutes of Health (UL1TR000075)
This publication has 43 references indexed in Scilit:
- Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disordersCurrent Opinion in Supportive & Palliative Care, 2013
- Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2Proceedings of the National Academy of Sciences of the United States of America, 2013
- VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effectsEMBO Molecular Medicine, 2013
- THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter studyMuscle & Nerve, 2013
- Novel Approaches to Corticosteroid Treatment in Duchenne Muscular DystrophyPhysical Medicine and Rehabilitation Clinics of North America, 2012
- Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsProceedings of the National Academy of Sciences of the United States of America, 2012
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyThe Lancet, 2011
- Dystrophin Immunity in Duchenne's Muscular DystrophyThe New England Journal of Medicine, 2010
- Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic MicePLOS ONE, 2010
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006